Preoperative Localization of Parathyroid Adenomas Using 4-Dimensional Computed Tomography: A Pictorial Essay  by Ellika, Shehanaz et al.
Canadian Association of Radiologists Journal 64 (2013) 258e268
www.carjonline.orgNeuroradiology / Neuroradiologie
Preoperative Localization of Parathyroid Adenomas Using
4-Dimensional Computed Tomography: A Pictorial Essay
Shehanaz Ellika, MDa,*, Suresh Patel, MDb, Todd Aho, MDb, Horia Marin, MDb
aDepartment of Radiology, Division of Pediatric Neuroradiology, Children’s Hospital Boston, Boston, Massachusetts, USA
bDivision of Neuroradiology, Department of Radiology, Henry Ford Health Systems, Detroit, Michigan, USAAbstract
Accurate preoperative localization is the key to successful parathyroid surgery in the era of minimally invasive parathyroid surgery. This
article presents and discusses the embryologic basis of parathyroid gland and ectopic location and different imaging modalities helpful in
diagnosing and localizing parathyroid adenomas and/or hyperplasia. We also aim to review the current surgical concepts in treatment of
parathyroid adenomas and/or hyperplasia, the utility of 4-dimensional computed tomography for accurate preoperative localization of
hyperfunctioning parathyroid glands, imaging classification of adenomas and/or hyperplasia, and, finally, present some of the limitations
of 4-dimensional computed tomography.Resume
Il est essentiel d’effectuer une localisation preoperatoire exacte pour assurer la reussite d’une chirurgie des parathyro€ıdes en cette ere de
chirurgie parathyro€ıdienne a effraction minimale. Cet article presente et analyse les bases embryologiques des glandes parathyro€ıdes et de
l’emplacement ectopique, ainsi que les differentes modalites d’imagerie pouvant aider a diagnostiquer et a localiser les adenomes
parathyro€ıdiens et l’hyperplasie des glandes thyro€ıdes. Nous visons egalement a analyser les concepts chirurgicaux qui regissent actuellement
le traitement des adenomes parathyro€ıdiens et l’hyperplasie des glandes parathyro€ıdes, l’utilite de la tomodensitometrie quadridimensionnelle
pour la localisation preoperatoire exacte de glandes parathyro€ıdes hyperactives et la classification des images d’adenomes et d’hyperplasie et
enfin, a presenter certaines limites de la tomodensitometrie quadridimensionnelle.
 2013 Canadian Association of Radiologists. All rights reserved.Primary hyperparathyroidism (PHPT) is characterized by
overproduction of parathyroid hormone (PTH) with high
normal or increased serum calcium concentrations. The
causes of PHPT include single adenomas (85%), double
adenomas (2%-12%), multigland disease (MGD) (5%-15%),
and, rarely, parathyroid carcinomas (<1%) [1e3]. PHPT
may be symptomatic and present clinically with renal calculi,
osteoporosis, neuropsychiatric symptoms, peptic ulcer
disease, or pancreatitis. In the past few decades, the diag-
nosis of PHPT has become more common due to routine
serum calcium measurements introduced in the 1970s [4].
The diagnosis in such cases is made biochemically, with no
obvious symptoms; in fact, such patients may have vague
neurocognitive symptoms or altered quality of life (pain,* Address for correspondence: Shehanaz Ellika, MD, Department of
Pediatric Neuroradiology, Childrens Hospital of Boston, 300 Longwood
Ave, Boston, MA 02115, USA.
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http://dx.doi.org/10.1016/j.carj.2012.03.002fatigue, depression, etc) that may not be recognized as being
associated with PHPT [5].
Over the past decade, the surgical treatment of para-
thyroid disease has changed considerably. Surgical treatment
of PHPT due to parathyroid adenoma or hyperplasia is
successful in 95% of cases in which traditional bilateral
4-gland exploration is performed [6]. More recently, unilat-
eral minimally invasive directed parathyroidectomy (MIP)
has been preferred because it minimizes operative compli-
cations [7]. When combined with intraoperative PTH assay,
this technique demonstrates high cure rates and low
complications rates, and avoids both general anesthesia and
overnight hospital stays associated with classic bilateral neck
exploration [8]. High-quality preoperative localization
imaging is important to the success of these strategies [9,10].
Imaging modalities such as sonography and sestamibi-
SPECT (single photon emission computed tomography)
demonstrate high specificity when concordant but subop-
timal sensitivity in most hands. In addition, ectopicll rights reserved.
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sible regions such as the mediastinum, benefit from evalua-
tion with a cross-sectional imaging technique [11].
Four-dimensional (4D) computed tomography (CT)
addresses many of the drawbacks of existing technology and
is a novel method of multiphase CT imaging [10,12e14].
Moreover, 4D-CT is a rapid study, easily reproducible, and
provides high-resolution anatomic detail useful for surgical
planning. In several recent series, CT was found to be more
sensitive than other modalities in localizing parathyroid
adenomas [10,13].
Embryology and Anatomy
There are 2 superior and 2 inferior parathyroid glands in
most individuals. The superior parathyroid glands along with
the lateral lobes of the thyroid originate from the fourth
pharyngeal pouch (Figure 1), and, as they lose their attach-
ment with the pharyngeal wall, they attach to the posterior
surface of the caudally migrating thyroid [15,16]. They have
a much shorter migration distance compared with the inferior
parathyroid glands, which accounts for their more predictable
location [17]. They generally are at the level of the upper two-
thirds of the thyroid gland. The inferior glands arise from the
third pharyngeal pouch along with the thymus gland
(Figure 1). While the dorsal wing of the third pharyngeal
pouch gives rise to the inferior parathyroid glands, the ventral
wing gives rise to the thymus [15]. As the primitive inferior
parathyroid glands lose their connection with the pharyngeal
wall, they join the thymus as it travels caudally and medially
to its final position in the mediastinum [15,18]. This migration
of the inferior parathyroid glands with the thymus accounts
for the fact that they are usually found in a plane ventral to
that of the superior parathyroid glands [18], and, for the same
reason, ectopic inferior parathyroid glands can be found
anywhere along this large area of descent up to the superiorFigure 1. The superior parathyroid glands (long grey arrows) arise embry-
ologically from fourth (IV) pharyngeal pouch and descend only slightly
during embryologic development. The inferior parathyroid glands (short
black arrows) arise from the third (III) pharyngeal pouch along with the
thymus; hence, they often descend with the thymus (long black arrow).border of the pericardium [19] but are most commonly
located inferior, posterior, or lateral to the lower thyroid pole
(69%) (Figure 2) [9]. Because of normal embryologic
migration of the parathyroid glands, there are characteristic
locations in which to look for adenomas: the midline of the
neck between the lateral margins of the carotid spaces and
anterior or anterolateral to the spine [11]. Craniocaudally
most are located between the hyoid and tracheal carina,
posterior to the thyroid gland [14,20].
Although oropharyngeal or parapharyngeal adenomas
have been reported, they are rare [20]. As a general rule,
ectopic adenomas in the upper neck are posteriorly located in
the retropharyngeal or retrovisceral spaces, although they
may be adjacent to the carotid space. Below the thyroid and
in the upper mediastinum, adenomas are typically anteriorly
positioned within the thymus or ventral mediastinum
(Figure 2) [20]. The reported incidence of ectopic adenomas
ranges from 20%-25% of cases of PHPT [11,13]. Ectopic
locations for parathyroid adenomas include the following:
paraesophageal-retroesophageal region (Figure 3), intra-
carotid sheath (more commonly inferior glands) (Figure 4),
mediastinal (Figure 5), intrathyroidal (more commonly
superior glands), retropharyngeal (more commonly superior
glands), intraneural sites, and associated with the thymus
(more commonly inferior glands) [14,20e22]. An under-
standing of these variations and normal migration patterns of
parathyroid glands is not only of utmost importance to the
surgeon who is planning to resect a hypersecreting adenoma
but also to the radiologist because it helps guide the radiol-
ogist’s attention when reviewing scans [11].
Current Surgical Concepts for Parathyroid Adenoma
and/or Hyperplasia
Parathyroidectomy is the only curative therapy for PHPT.
Any symptomatic PHPT should be referred for surgical
intervention. Most patients with hyperparathyroidism are
‘‘asymptomatic’’ and to address the management of these
asymptomatic patients, the National Institutes of Health
Consensus Development Panel recommended para-
thyroidectomy for the following asymptomatic patients: (a)
patients <50 years old, (b) patients who cannot participate in
appropriate follow-up, (c) patients with a serum calcium level
>1.0 mg/dL above the reference range (8-10mg/dL), (d)
patients with a urinary calcium level >400 mg for 24 hours,
and (e) patients with a >30% decrease in renal function [23].
The treatment goal for patients with PHPT is operative
excision of an adequate amount of hyperfunctioning para-
thyroid tissue to render the patient eucalcemic after surgery
[24]. The criterion standard for many decades for the treat-
ment of PHPT is bilateral neck exploration, with the patient
under general anesthesia, for removal of hyperfunctioning
parathyroid glands, with a cure rate of 90%-95% in the hands
of an experienced endocrine surgeon [25e27]. A transverse
cervical incision is made approximately 2 cm above the
sternal notch, just below the cricoid cartilage, which permits
identification of all 4 glands and allows access to nearly all
Figure 2. Consecutive axial 4-dimensional (4D) computed tomography (CT) in the venous phase from superior (A) to inferior (B), showing heterogeneously
enhancing adenoma (short black arrows) at the posterior inferior margin of the right thyroid gland. The adenoma is in the anterior-posterior plane of thyroid and
anterior to trachea. A coronal view from a 4D-CT study in the venous phase (C), showing heterogeneously enhancing adenoma (short black arrow) inferior to
right lobe of the thyroid gland with the cleavage plane between adenoma and thyroid gland (long black arrow). Delayed sestamibi scans (D, E) shows persistent
asymmetric radiotracer activity (white arrows) adjacent to thyroid gland posterior and inferior to inferior pole of the right thyroid gland.
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Figure 3. A 71-year-old woman with hypercalcemia noted on laboratory examination and who also had symptoms suggestive of osteoporosis. Axial
4-dimensional computed tomography from caudal (A) to cranial (B) in arterial phase shows an adenoma in the retroesphageal region (black arrows) that is
straddling the midline. At the superior aspect of this retroesophageal adenoma is a small, rounded area of enhancement (white arrow) just posterior and medial
to posterior aspect of middle third of the left lobe of thyroid gland. This is separate from the thyroid gland and is separate from the much larger retroesophageal
adenoma. Delayed sestamibi scans (C, D) showing abnormal radiotracer accumulation on the delayed images about the midline (thin black arrows) just
proximal to the thoracic inlet which is suspicious for a parathyroid adenoma. The more superior left sided lesion was not visualized on the nuclear scan.
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the opportunity to inspect all 4 parathyroid glands and to
resect the abnormal gland [28]. In cases of solitary para-
thyroid adenomas, all 4 glands are sampled, and the
enlarged, adenomatous gland is resected [9], whereas for
MGD, the approach involves either a subtotal 3.5-gland
resection with cryopreservation or a total para-
thyroidectomy with autotransplantation into the forearm or
neck muscle [9]. However, bilateral cervical exploration
requires a larger incision, a longer operating time, and
potentially higher morbidity. Because more than 85% ofFigure 4. A 57-year-old woman who had routine laboratory workup, prior to kne
(PTH) levels (PTH ¼ 296 pg/mL). Past medical history was significant for dia
computed tomography study in the arterial phase (A) showing heterogeneously en
situated within the carotid sheath, between and splaying internal jugular vein (sho
images (B) there is washout of contrast within the adenoma (long white arrow).patients with PHPT have a single-gland adenoma, 4-gland
exploration may not be necessary in most patients if the
enlarged parathyroid gland can be identified and localized
before surgery [29].
More recently, with improved preoperative localization,
more targeted and focused surgical techniques have become
available, collectively known as minimally invasive para-
thyroidectomy (MIP), with an approach to minimize surgical
trauma that results in lower morbidity due to decreased
operative time, reduced hospital stay, improved cosmetic
result, use of local rather than general anesthesia, and no riske surgery, which revealed hypercalcemia and elevated parathyroid hormone
betes, hypertension, and renal stones. Coronal views from a 4-dimensional
hancing adenoma (long white arrows) superior to right lobe of thyroid gland
rt white arrow) and common carotid artery (white arrowhead). On the delayed
Figure 5. A 61-year-old woman with elevated calcium levels on biochemical profile. Axial 4-dimensional computed tomography images in the arterial (A) and
venous phase (B) showing an anterior mediastinal adenoma (white arrows). The adenoma was not in continuity with thyroid gland and does not washout
significantly on the delayed phase (white arrow) (B). Delayed sestamibi scans (C, D) shows persistent focal round area of intense radiotracer uptake within right
anterior mediastinum (black arrows). At surgery the right inferior parathyroid gland was identified, noted to be very enlarged, and located in right thyrothymic
ligament. Intraoperative parathyroid hormone (PTH) level (E) dropped from 207.8 to 42.0 after removal of the enlarged gland. This figure is available in colour
online at http://carjonline.org/.
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practiced minimally invasive techniques include unilateral
open parathyroidectomy, video-assisted parathyroidectomy,
and videoscopic parathyroidectomy [9]. The unilateral open
technique involves a small unilateral transverse or lateral
incision for access to the parathyroid adenoma [9]. The
video-assisted technique is performed without insufflation by
using a 5-mm endoscope and small conventional instruments
through a 1.5-cm midline incision to identify and resect the
abnormal gland or glands [9]. Videoscopic techniques use
carbon dioxide insufflation to create a working space for
dissection and use 3 small incisions and endoscopic instru-
ments to remove the abnormal gland, usually from a lateral
cervical approach [9].
MIP is guided by rapid intraoperative PTH assay, with
a greater than 50% reduction in the peripheral venous PTH
levels 10 minutes after parathyroid gland resection compared
with the preexploration level, accurately predicts removal of
all offending parathyroid tissue and is indicative of cure
[9,29,38,39]. Intraoperative PTH is not uniformly used, and
there are proponents who suggest use with every case [40],
just as there are critics of the technique [41].
Preoperative Localization
Imaging has no role in the diagnosis of PHPT but is
helpful for preoperative localization of enlarged parathyroid
glands (adenomas and/or hyperplasia). If a minimallyinvasive operative approach is being considered, then
preoperative localization is essential [5] and the goal of
localization is to identify uniglandular disease and to help
select patients most appropriate for unilateral and minimally
invasive procedures [5,9,42].
A wide variety of imaging techniques, including sesta-
mibi-based scintigraphy, ultrasonography, CT, magnetic
resonance imaging, and more recently, 4D-CT have been
used alone and in combination as first-line studies to localize
abnormal parathyroid glands in patients with PHPT. Ultra-
sonography and technetium 99mesestamibi scintigraphy are
usually the first-line diagnostic modalities for routine
preoperative imaging localization of a parathyroid adenoma
because these tests are inexpensive, easy to perform, and
have good detection rates [43]. Sestamibi-based scintigraphy
has several major limitations, including poor anatomic detail
of sestamibi scans that are done without CT, and its poor
sensitivity in identifying patients with PHPT due to MGD.
Anatomic detail can be improved with sestamibi-SPECT and
SPECT-CT; however, this is time consuming, typically
available in specialized centers, and images can be degraded
by patient motion [44e46].
In contrast, ultrasonography provides good anatomic
information about masses in the neck but is less informative
about function. When used together, these imaging modal-
ities complement each other and increase the success rate of
MIP: nuclear medicine scan offers functional information,
whereas ultrasound shows more detailed anatomic
Figure 6. A 51-year-old woman found to have asymptomatic primary hyperparathyroidism on biochemical evaluation. Axial images from a 4-dimensional
(4D) computed tomography (CT) examination in arterial (A) and venous (B) phase, showing an adenoma (white arrowheads) in close proximity to the
posterior surface of upper lobe of right hemithyroid (white arrows), which enhances on the early arterial phase (A), with early washout on the venous phase
(B). There is a cleavage plane between the adenoma and the thyroid gland (A, long black arrow). (C, D) Delayed sestamibi scans, showing focal persistent
radiotracer uptake within the region of the upper aspect of the right lobe of the thyroid (short black arrows) consistent with parathyroid adenoma visualized on
4D-CT.
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ultrasonography may still be inadequate for preoperative
localization in patients with a history of previous neck
surgery, in patients with coexisting thyroid disease (eg,
thyroid nodules or Hashimoto thyroiditis), and in patients
with an unfavorable body habitus (eg, obesity, short neck,
or kyphosis) [10]. Most studies in the literature on para-
thyroid imaging report the ability of an imaging modality to
localize and/or lateralize parathyroid tumours to the correct
side of the neck [48,50e55]. Sensitivity for lateralization
by ultrasonography varies from 61%-88% [48,50e55];
whereas sensitivity for lateralization by sestamibi varies
from 68%-86% [48,51e55].
4D-CT
4D-CT allows identification of hyperfunctioning para-
thyroid glands; the name is derived from 3-dimensional CT
scanning with an added ‘‘fourth’’ dimension that represents
the perfusion information derived from noncontrast, arterial,
and delayed (venous) phase imaging [10,14]. The images
that are generated by 4D-CT provide both anatomic andfunctional information (based on changes in perfusion) in
a single study that can be easily interpreted (Figures 6, 7)
[10]. The hyperfunctioning parathyroid glands demonstrate
intense arterial phase enhancement with early washout in the
venous phase of 4D-CT (Figures 6, 7) [10,13]. One of the
challenges in interpretation of 4D-CT images is differentia-
tion of parathyroid adenomas from exophytic thyroid
nodules. A recent study by Vu et al [56] that used muliphasic
multidetector CT with unenhanced, arterial, venous, and
delayed phases, showed that (a) parathyroid adenomas had
lower baseline density than thyroid glands on unenhanced
images, (b) parathyroid adenomas showed a greater increase
in density from baseline to arterial phase than normal thyroid
tissue on the enhanced scans, and (c) parathyroid adenomas
washout contrast much faster than thyroid tissue in the
venous and delayed phases (Figure 7) [56], which allows
easy differentiation from thyroid nodules (minimal arterial
phase and persistent venous enhancement). Another potential
challenge while interpreting a 4D-CT includes differentiating
parathyroid adenomas from normal lymph nodes and
vascular structures. Lymph nodes do not show arterial phase
enhancement and are most often isoenhancing relative to
Figure 7. Axial images of a 4-dimensional (4D) computed tomography (CT) study in the arterial (A) and venous (B) phase, showing an adenoma (black arrows)
posterior to left inferior third of thyroid. (B) On the venous phase, there is washout of this adenoma when compared with the thyroid gland. Coronal (C) and
sagittal (D) reconstructions from a 4D-CT study in the arterial phase, showing the adenoma (black arrows) adjacent to the posterior aspect of the inferior
portion of the left hemithyroid. Along its lateral margins is the inferior thyroidal artery (white arrows).
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by carefully tracking them in the CT performed during early
arterial phase enhancement [11].
4D-CT showed significantly improved sensitivity for precise
localization to a quadrant of the neck (range, 70%-88%)
compared with both sestamibi scanning (range, 33%-65%) and
ultrasonography (range, 29%-57%) [10,13]. More recently,
Chazen et al [57] determined the accuracy of 4D-CT to
correctly lateralize adenomas to be 93%, which allows the
surgeon to perform a unilateral neck dissection with associated
decreasedmorbidity and length of hospital stay. 4D-CThas also
been shown to have better sensitivity for the detection ofMGD,
which is a common cause for repeated surgery (Figure 8) [10],
with sensitivity that ranges from 44%-45% in detecting MGD
[10,57], and 100% specificity for ruling out MGD [57]. This is
in sharp contrast to sestamibi, which identified MGD in only
9%, and ultrasound, which was not able to recognize MGD, in
a study done by Rodgers et al [10]. In addition, the finding of
MGD on preoperative 4D-CT changed the operative approach
(ie, fromMIP to a 4-gland exploration) in some of their patients[10]. A recent study by Eichhorn-Wharry et al [58] showed that
4D-CT had an advantage in a specific subset of patients with
mild hypercalcemia, elevated PTH, and smaller gland weights
compared with sestamibi scanning.
Our practical experience in reviewing 4D-CT studies has
shown a learning curve for identifying parathyroid
adenomas, especially when they are ectopic. Familiarization
with the usual appearance and locations of parathyroid
adenomas leads to higher detection rates [11]. There are
different imaging protocols for 4D-CT, with protocols that
range from precontrast imaging to arterial, venous, and
delayed phase imaging [10] to more modified 4D-CT
protocols with 2 sets of CT imaging (one before the infusion
of contrast and the second during and just after infusion of
contrast) and no delayed imaging [45]. At our institute, the
noncontrast phase has been removed from our protocol
because we did not find that it helped with diagnosis, and it
added to the radiation dose; this has also being described by
other researchers [14]. We routinely obtain images presently
in the arterial and venous phases only. Our protocol involves
Figure 8. A 31-year-old man with end stage renal disease and secondary
hyperparathyroidism. Preoperative parathyroid hormone was 7376 pg/mL.
(A-C) Axial images from a 4-dimensional (4D) computed tomography (CT)
study in the arterial phase from superior to inferior, showing 3 adenomas.
Two adenomas are located bilaterally along the posterior surface of the right
and left lobes of the thyroid gland (black arrows). The largest lesion arises
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after intravenous administration of 100 mL of iodinated
contrast (Optiray 350; Mallinckrodt, Hazelwood, MO; 350
mg/mL) at a rate of 5 mL/s. We acquire contiguous axial
images from the base of the orbit to the level of the aorto-
pulmonary window in arterial (22-second delay) and venous
phases (immediately after the arterial phase) with the
following settings: 1.25 section thickness; gantry rotation
time, 0.8 seconds; 20-23 cm field of view (depending on
patient body habitus); 120 kV (peak); and automatic tube
current modulation. Reformatted images in the 2 phases are
sent to Picture Archival and Communication System (PACS)
as 2.5-mm-thick contiguous images in the coronal, and
sagittal planes.
Imaging Classification of Parathyroid Adenomas and/or
Hyperplasia
Currently, there is no standardized means of describing
parathyroid adenoma locations. Description of an adenoma
and/or hyperplasia location is important to facilitate surgical
and anesthesia planning, especially for MIP and also for
repeated surgery in cases of persistent or recurrent disease
[10,58]. The nomenclature by Perrier et al [59] emphasizes
the anterior-posterior location of enlarged parathyroid glands
in reference to the thyroid parenchyma, trachea, and esoph-
agus and also categorizes the glands embryologic origin [60].
Glands are classified from A-G: a type A gland is adherent to
the posterior thyroid parenchyma in the expected location of
the normal gland. A type B gland is behind the thyroid
parenchyma and lies in the tracheoesophageal groove. An
undescended gland high in the neck near the carotid bifur-
cation or mandible is classified as a type B plus gland. A type
C gland is caudal to the thyroid parenchyma, in the trache-
oesophageal groove, and type D glands are intimately
attached to the mid posterior surface of the thyroid gland in
proximity to the expected location of the recurrent laryngeal
nerve. A type E gland is the most externally located gland
because it is not deep in the neck and is easy to resect. A type
F gland is an ectopic gland located in the thyrothymic liga-
ment, and a type G gland is intrathyroidal [59]. This clas-
sification improves communication between radiologists and
surgeons; however, one of the disadvantages of this classi-
fication is that it is more clinically derived.
More recently, Zald et al [61] described 4 quadrants and
ectopic gland locations for parathyroid adenomas. Type A
and type B adenomas are located to the right and to the left
of the midline located above the most inferior extent of thefrom the inferior aspect of the left lobe of the thyroid gland (short white
arrow). (D) Coronal delayed sestamibi scan, demonstrating focus of
increased radiotracer activity in the region of the inferior left thyroid lobe
(long white arrow). The other 2 adenomas seen on 4D-CT were not visu-
alized on the nuclear scan. At surgery, left inferior parathyroid gland was
very large, along the lateral and inferior pole of the thyroid, right and left
superior glands were enlarged. The right inferior parathyroid was identified
within the thyrothymic tract and appeared normal.
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and type D glands are located inferior to the right and left
lobes of the thyroid, respectively, above the sternal notch,
which thus allows surgical excision through a cervical
approach. Type E glands are located in unusual ectopic
location such as the carotid sheath, thoracic mediastinum, or
retroesophageal region [61]. This classification system
appears to be simpler and more amenable to use by radiol-
ogists and has been used in recent publications on 4D-CT of
parathryroid adenomas [47,61].
Limitations of 4D-CT
Parathyroid glands located within the thyroid (subcapsular
adenomas) are difficult to identify on CT and ultrasonog-
raphy in these instances is useful to delineate the parathyroid
gland by demonstrating a more hypoechoic structure in
relation to the thyroid [62]. Other areas in which parathyroid
glands are more difficult to distinguish on CT include the
sternal notch area (given the location near bone) and in the
mediastinum (where parathyroid adenomas can be confused
for lymph nodes) [62]. Scanning artifacts related to swal-
lowing and breathing may limit evaluation of the study [63].
Furthermore, streak artifact from the shoulders and clavicles
can mask parathyroid adenomas on CT, and, in these
instances, lifting the patient’s shoulders while scanning the
patient might be helpful [62]. Occasionally, streak artifact
from contrast material in adjacent vessels can obscure
parathyroid adenomas, and, in such cases, patient’s surgical
history and prior imaging should be reviewed before the
4D-CT examination to decide which side to use for intra-
venous injection to minimize streak artifact from dense
inflowing contrast medium [47]. In addition, after identifying
1 adenoma, it is important to continue searching for addi-
tional adenomas because the discovery of a second adenoma
may significantly alter the planned surgery [47].
The other major limitation of 4D-CT is the radiation dose
to the patient, especially in cases in which images are
acquired during multiple phases. We use dose-reduction
techniques with 4D-CT, as described by Welling et al [14]
and Chazen et al [57], including automatic tube current
modulation, avoidance of the brain and orbits, and elimina-
tion of precontrast and the more delayed phases of imaging.
Despite these techniques, 4D-CT delivers a significant radi-
ation dose. The CT dose index for single phase of the CT is
aproximately 15 mGy [63]. When using the published dose
length product to effective dose conversion factor of 0.0054
mSv/(mGy/cm), the estimated effective dose from a 4D-CT
is 10 mSv [64]. This compares with an effective dose from
a technetium 99mesestamibi nuclear medicine SPECT,
which results in an effective dose of 6 mSv when assuming
the administered radioactivity is 740 MBq or 20 mCi [65]. If
additional CT localization is added to the SPECT, then the
effective dose increases to about 8-9 mSv, depending on the
technical factors used for the CT part of the study [66].
Finally, patients who cannot receive intravenous contrast
benefit less from this study, given the importance ofintravenous contrast to differentiate parathyroid glands from
surrounding structures, especially lymph nodes [62].
Conclusion
4D-CT is a new and emerging imaging technique for
preoperative parathyroid adenoma and/or hyperplasia local-
ization to plan the best surgical approach. 4D-CT is helpful
due to higher spatial resolution and additional functional
information characteristic of parathyroid adenomas that it
provides. The most high yield areas for a focused search
included the locations between the carotid sheaths from
hyoid bone to the carina. The locations of parathyroid
adenomas missed by conventional methods and detected by
4D-CT include ectopic adenomas and those located in the
tracheoesophageal groove, carotid sheath, and the medias-
tinum. The radiation dose, however, remains a limitation.
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